Kx Advisors’ cover photo
Kx Advisors

Kx Advisors

Business Consulting and Services

Washington, District of Columbia 19,969 followers

About us

For more than 40 years, Kx Advisors (operating as Kaiser Associates’ Healthcare Practice) has provided strategy consulting services to help healthcare executives achieve critical business growth goals. With a highly collaborative approach they have developed pragmatic solutions for leading pharmaceutical, biotechnology, medical device, health IT, digital health, and diagnostics clients, with data-driven insights to give those clients the tools to compete and win across the healthcare industry.

Website
http://www.kxadvisors.com
Industry
Business Consulting and Services
Company size
51-200 employees
Headquarters
Washington, District of Columbia
Type
Privately Held
Specialties
Pharmaceuticals, Medical device, Diagnostics, Life sciences, Digital health, Health IT, Mergers and acquisitions, Pricing, Market access, Portfolio planning, Healthcare, Medical Technology, Strategy Consulting, and Product Launch

Employees at Kx Advisors

View 88 employees at Kx Advisors

or

By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.

See all employees

Locations

Updates

  • We're proud to share that Hilary Gentile, Chief of Commercial Strategy and Innovation at BGBx Consulting has been recognised as an ELITE 2026 Strategist by PM360 Magazine!   Across more than two decades in healthcare and life sciences, Hilary has built a reputation for anticipating shifts before they materialize. At BGBx Consulting, Hilary brings together strategy, innovation, and intelligence in developing AI-driven, proprietary tools that unlock insight into healthcare decision-making. This well-deserved recognition reflects the strategic leadership, expertise, and thoughtful guidance Hilary brings to clients, teams, and the broader healthcare industry.    Read more about Hilary's recognition here: https://lnkd.in/ebpnrxJK   Congratulations, Hilary, on this outstanding achievement. We're delighted to see your leadership recognised.   #PM360 #HealthcareMarketing #Strategy #Innovation

    • No alternative text description for this image
  • View organization page for Kx Advisors

    19,969 followers

    We are excited to announce that Kx is now part of BGBx Consulting, bringing together Kx Advisors, Hayden Consulting Group, and the BGB Group Innovation & Intelligence team.   This evolution strengthens our ability to support clients by combining deep strategic expertise, innovative thinking, and industry-leading insights under one consulting division. While our name is changing, the trusted team, specialized expertise, and client-focused approach that have defined Kx Advisors remain the same.   As part of BGBx Consulting, our clients will benefit from broader capabilities, diverse perspectives, and expanded resources to help navigate the healthcare industry's most complex challenges.   We look forward to this exciting new chapter as BGBx Consulting and continuing to partner with our clients to drive meaningful impact.

    • No alternative text description for this image
  • Kx Advisors reposted this

    I know I've been a bit MIA but I'm here to share in #SumUpSaturday on #VBC and #reimbursement in #MSK! In case you didn't hear, at the start of the week, CMS kind of quietly announced that starting in 2027 ALL Medicare lower extremity joint arthroplasty in the hospital (hip, knee AND ankle) will be subject to bundled payments... this is in addition to TEAMs. My go to VBC expert Benjamin Schwartz, MD, MBA first shared this post below. Christian explains it better than I could. This raises a lot of questions and challenges in an already cost contained environment. Arguably, this further supresses surgeon autonomy and decision making. While innovation will likely be evaluated by VACs with a broader lens, scrutiny on ability to reduce costs, not just improve workflows and outcomes will be even higher. Will share more thoughts as I work through the implications. Meanwhile, CMS and FDA announced their 3rd iteration of breakthrough device reimbursement to replace TCIT named RAPID. Is 3rd time a charm? https://lnkd.in/e4HumGMC

    View profile for Christian Pean M.D., M.S.

    Executive Director of AI and IT Innovation at Duke Orthopedic Surgery, Orthopedic Trauma Surgeon | CEO and Co-Founder of RevelAi Health

    On October 1, 2027, essentially every IPPS hospital in the United States that isn't already in TEAM will be mandatorily at 90-day episode risk for hip, knee, and ankle replacement. CJR-X is the most aggressive expansion of mandatory episode-based payment in the history of the Innovation Center. The original CJR model ran in 67 MSAs from 2016 to 2024 and generated $112.7M in net Medicare savings across 98,000 episodes at 323 hospitals while maintaining quality. CMS read that result and concluded, reasonably, that the intervention works. CJR-X takes it nationwide, bolts on outpatient LEJR and total ankle, keeps the 90-day window, adds a quality-first composite score gate, a 5% stop-loss for dual-eligible-heavy hospitals, 29 risk adjusters, and a waiver of the SNF 3-day stay rule. Projected 5-year savings: $725M. Read it alongside TEAM and the doubling down on accountable care seems more steadfast. TEAM holds 729 hospitals accountable for 30-day surgical episodes starting this year. CJR-X picks up almost everyone else for 90-day joint replacement episodes starting late 2027. Together they represent something CMS has never done before: near-universal mandatory episode risk for orthopedic surgery. This lands at a difficult moment. Primary TJA reimbursement is down 56% since 2000. The 2026 Physician Fee Schedule added another 2.5% efficiency cut on surgical procedures. Demand is projected to nearly triple by 2040. You cannot keep compressing procedural payment on the most cost-effective intervention in all of medicine and simultaneously expand episode accountability without building new infrastructure to capture value beyond the cut. Benjamin Schwartz, MD, MBA and I are going to dig in on the model Thursday: → What does CJR-X change for hospitals already thinking about TEAM — and what does it mean for the ones that assumed mandatory bundles wouldn't reach them? → Where does the 90-day window create real operational opportunity (post-acute navigation, PT partnerships, readmission prevention) versus where it creates brittle risk for hospitals without the infrastructure to manage it? → How do we think about gainsharing, physician alignment, and the role of ASCs and HOPDs as outpatient LEJR volume keeps migrating? Going live Thursday on the Techy Surgeon Substack with Benjamin Schwartz, MD, MBA to dive in on the model and discuss the shifting incentives of musculoskeletal care. If you're an orthopedic surgeon, hospital CFO, a service-line leader, or anyone trying to make sense of where MSK value-based care is actually heading — come join us. A reminder, public comment on CJR-X closes June 9. (Also if you haven't checked out the new Chat GPT Image module it's pretty incredible and made the anime portrait of us below).

    • No alternative text description for this image
  • Kx Advisors reposted this

    In today’s fast-evolving, resource-constrained healthcare landscape, successful start-up commercialization requires more than just great science. 💭 Jenny Knauss, PhD, Vice President at Kx Advisors, a BGB Group Company shares her perspective on key elements for commercial success - from selecting the right agency partners to the evolving role of AI and data-driven marketing in the latest PM360 Magazine Think Tank. 👉 Read the full article here (page 42): https://lnkd.in/evuUrXEx Interested in discussing these themes further? 📧 Contact Jenny at jenny.knauss@kxadvisors.com

    • No alternative text description for this image
  • In today’s fast-evolving, resource-constrained healthcare landscape, successful start-up commercialization requires more than just great science. 💭 Jenny Knauss, PhD, Vice President at Kx Advisors, a BGB Group Company shares her perspective on key elements for commercial success - from selecting the right agency partners to the evolving role of AI and data-driven marketing in the latest PM360 Magazine Think Tank. 👉 Read the full article here (page 42): https://lnkd.in/evuUrXEx Interested in discussing these themes further? 📧 Contact Jenny at jenny.knauss@kxadvisors.com

    • No alternative text description for this image
  • Kx Advisors is proud to be recognised again as a top firm to work for in the 2026 Vault Consulting rankings! 🏆 Top 50 Consulting Firms in North America  🌍 Top 25 Consulting Firms in EMEA ✨ Kx ranked within the Top 10 across key areas that matter most to our people and clients including firm leadership, culture, promotion policies, training & client interaction. 👩💼 We’re especially proud to be ranked #7 Best Consulting Firm for Women — a recognition that reflects our ongoing commitment to inclusion, equity, and growth at every level. Thank you to our Kx colleagues for shaping a culture we’re proud of, and to our clients for our continued collaboration and partnerships. 👉 See our full Vault rankings linked in the comments below. #VaultRankings #Consulting

Affiliated pages

Similar pages

Browse jobs